When is bile secreted

Powerful new tools of molecular and cell biology Great advances in understanding canalicular transport have been made in the past two decades. Bile as a digestive secretion Luminal events: Bile is a key digestive secretion, and thus joins saliva, gastric and pancreatic juice as a functional secretion enabling the highly efficient assimilation of dietary foodstuffs.

Figure 1 Schematic depiction of the antimicrobial effects of bile acids in the small intestinal lumen. Figure 1. Figure 2 Schematic illustration of the enterohepatic circulation of bile acids. Figure 2. Figure 3 Schematic depiction of the enterohepatic circulation and metabolism of bile acids. Figure 3. Figure 4 Schematic illustration of the bile acid transport by the ileal enterocyte.

Figure 4. Figure 5 Schematic illustration of bile acid transport by the hepatocyte. Figure 5. Use of conjugated bile acids would be investigational.

Ox bile salts are available as nutritional supplements Defective canalicular transport because of deficiency in bile salt export pump BSEP or canalicular dysfunction; bile acid retention in hepatocytes and plasma; bile acid deficiency in small intestinal lumen Primary familial intrahepatic cholestasis, type II neonatal hepatitis on biopsy Reduce toxicity of retained bile acids Remove retained bile acids Prevent inappropriate ileal absorption of any secreted bile acids Enrich diet in triglycerides whose fatty acids are water soluble Replace defective hepatocytes or entire liver UrsodiolExtracorporeal albumin dialysisBile acid sequestrantsAdd medium chain triglycerides to dietHepatocyte infusion or liver transplantation Some 50 defects in BSEP have been identifiedGenerally, infants progress to liver failure and require liver transplantation.

Pathophysiological disturbance Disease condition Rationale of therapy Agent or procedure Comment Defective bile acid uptake by hepatocytes because of defective uptake proteins; bile acid retention in plasma Intractable pruritis and elevated plasma bile acid levels Remove retained bile acids from plasma Decrease return of bile acids to the liver Extracorporeal albumin dialysisBile acid sequestrants Condition not yet described Defective bile acid flow because of ductular destruction or obstruction; bile acid retention in hepatocytes and plasma; bile acid deficiency in small intestine Primary biliary cirrhosis; primary sclerosing cholangitis, cholanopathies Decreased cytotoxicity of circulating bile acids; decreased oxidative stress; antiapoptotic effects UDCA plus, in some cases, adjuvant steroids ; medium chain triglycerides for nutrition; fat soluble vitamins parenterally.

Sequestrants for pruritus UDCA improves liver tests and long term survival. Other conjugated bile acids have not been tested.

Handbook of Physiology. Section on the Gastrointestinal System, pp. Enterohepatic circulation of bile acids. In: Handbook of Physiology. The Gastrointestinal System. Volume III. Salivary, gastric, pancreatic, and hepatobiliary secretion, pp. Bile formation and the enterohepatic circulation. Physiology of the Gastrointestinal tract, pp. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol, 43 , pp. Nuclear receptor regulation of lipid metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases.

Curr Opin Investig Drugs, 6 , pp. Pflugers Arch, ,. Bile salt excretory pump: biology and pathobiology. J Pediatr Gastroenterol Nutr, 43 , pp.

Adv Drug Deliv Rev, 55 , pp. Uptake and efflux transporters for conjugates in human hepatocytes. Methods Enzymol, , pp. Transporters for bile acids and organic anions. Pharm Biotechnol, 12 , pp. Enterohepatic bile salt transporters in normal physiology and liver disease.

Gastroenterology, , pp. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Coordinate transcriptional regulation of transport and metabolism. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene, 25 , pp. Preparation of basolateral sinusoidal and canalicular plasma membrane vesicles for the study of hepatic transport processes.

Mol Pharmacol, 60 , pp. Technology Insight: tuning into the genetic orchestra using microarrays—limitations of DNA microarrays in clinical practice. Nat Clin Pract Oncol, 3 , pp. Cholangiocyte-specific rat liver proteins identified by establishment of a two-dimensional gel protein database. Electrophoresis, 19 , pp. Proteome analysis of mitochondrial outer membrane from Neurospora crassa. Proteomics, 6 , pp. Bile acid secretion and direct targeting of mdr1-green fluorescent protein from Golgi to the canalicular membrane in polarized WIF-B cells.

J Cell Sci, , pp. Semin Liver Dis, 22 , pp. Hydrolysis and precipitates in carboxylate soap solutions. J Phys Chem, 70 , pp. The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem, , pp. The structure of conjugated bile salt-fatty acid monoglyceride mixed colloids: studies by small-angle neutron scattering. J Phys Chem, , pp. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.

The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest, 43 , pp. Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man.

J Clin Invest, 56 , pp. Influence of ingestion of cholesterol in the form of eggs on the composition of bile in healthy subjects. Z Ernahrungswiss, 10 , pp. Effect of beta-sitosterol alone or in combination with chenic acid on cholesterol saturation of bile and cholesterol absorption in gallstone patients.

Gastroenterology, 76 , pp. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, , pp. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.

Clin Ther, 28 , pp. M Medline. Curr Opin Lipidol, 12 , pp. J Lipid Res, 45 , pp. MJLR Medline. Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis. How bile acids confer gut mucosal protection against bacteria. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology, 37 , pp. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Physicochemical and physiological properties of cholylsarcosine.

A potential replacement detergent for bile acid deficiency states in the small intestine. J Clin Invest, 89 , pp. Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation. Gastroenterology, 98 , pp. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption.

Studies in dogs with ileal resection. Dig Dis Sci, 37 , pp. Conjugated bile acid replacement therapy for short-bowel syndrome. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.

Z Gastroenterol, 42 , pp. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome. J Pharm Pharmacol, 57 , pp. Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. Gastroenterology, 75 , pp. Hepatology, 43 , pp. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.

Genes Dev, 17 , pp. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

J Intern Med, , pp. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. G Medline. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.

Hepatology, 42 , pp. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Pediatr Gastroenterol Nutr, 39 , pp. S Medline. Hepatobiliary transporters and drug-induced cholestasis. Hepatology, 44 , pp. J Pharmacol Exp Ther, , pp. Drug Metab Dispos, 34 , pp. Mol Pharm, 3 , pp. Transport by vesicles of glycine-and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep.

Biochim Biophys Acta, , pp. A phylogenetic survey of biliary lipids in vertebrates. J Lipid Res, 46 , pp. Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res, 12 , pp. Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals.

Toxicol Appl Pharmacol, 85 , pp. Drug Metab Rev, 5 , pp. Visualization by electron microscopy. J Clin Invest, , pp. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Changes in gallbladder bile composition following gallstone formation and weight reduction. Equilibrium dialysis studies on aqueous taurocholate-lecithin solutions: further validation of the method.

Hepatology, 12 , pp. Mechanism by which bile salt disrupts the gastric mucosal barrier in the dog. J Clin Invest, 66 , pp. ABCB4 gene mutation-associated cholelithiasis in adults. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter gene ABCB4.

Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis. Am J Gastroenterol, 93 , pp. Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study. Gastroenterology, 83 , pp. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of nor-ursodeoxycholate in rodents.

Gastroenterology, 90 , pp. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol, 38 , pp. J Lipid Res, 47 , pp. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet, 44 , pp.

Effects of fasting on bile acid metabolism and biliary lipid composition in man. J Lipid Res, 17 , pp. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology, 97 , pp. Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43, twin pairs. Hepatology, 41 , pp. Am J Gastroenterol, 99 , pp. Subscribe to our newsletter.

Print Send to a friend Export reference Mendeley Statistics. Recommended articles. Cholesterol and Lipoprotein Metabolism and Atherosclerosis Bile Acid Multiple therapeutic targets in rare cholestatic liver Instructions for authors Submit an article Ethics in publishing Contact.

Gallstones , most of which are composed predominantly of cholesterol, result from processes that allow cholesterol to precipitate from solution in bile. Bile acids are derivatives of cholesterol synthesized in the hepatocyte. Cholesterol, ingested as part of the diet or derived from hepatic synthesis is converted into the bile acids cholic and chenodeoxycholic acids, which are then conjugated to an amino acid glycine or taurine to yield the conjugated form that is actively secreted into cannaliculi.

Bile acids are facial amphipathic, that is, they contain both hydrophobic lipid soluble and polar hydrophilic faces. The cholesterol-derived portion of a bile acid has one face that is hydrophobic that with methyl groups and one that is hydrophilic that with the hydroxyl groups ; the amino acid conjugate is polar and hydrophilic. Hepatic synthesis of bile acids accounts for the majority of cholesterol breakdown in the body.

In humans, roughly mg of cholesterol are converted to bile acids and eliminated in bile every day. This route for elimination of excess cholesterol is probably important in all animals, but particularly in situations of massive cholesterol ingestion. Interestingly, it has recently been demonstrated that bile acids participate in cholesterol metabolism by functioning as hormones that alter the transcription of the rate-limiting enzyme in cholesterol biosynthesis.

Large amounts of bile acids are secreted into the intestine every day, but only relatively small quantities are lost from the body. Venous blood from the ileum goes straight into the portal vein, and hence through the sinusoids of the liver. Bile acids are recycled between liver and small intestine i.

In addition to providing the detergent property of bile and being a major driving force of bile flow, bile acids are signalling molecules that carry signals from the intestine to the liver. Homeostasis of bile acid synthesis and ileal conservation is essential not only to achieve the physiological functions of bile acids, but also to avoid pathological effects caused by their amphipathic property. Bile acid retention in the hepatocyte due to bile duct disease e.

In terms of functional molecular imaging, dynamic planar cholescintigraphy is currently the modality of choice for the evaluation of the biliary system often with Tcm-mebrofenin as the radiotracer. Hepatic bile acid synthesis and handling, as well as intestinal malabsorption of bile acids, have been assessed by dynamic planar cholescintigraphy using the labelled bile acid analogue 75 SeHCAT.

Positron emission tomography PET using radiolabelled bile acid analogues has, to date, only been applied in preliminary studies regarding biliary secretion.